PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

September 3th, 2009 Issue 37 Vol. 9
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Pfizer Settles Whistleblower Case for $2.3 Billion
Pharma giant Pfizer must shell out $2.3 billion to settle a massive illegal marketing case involving the painkiller Bextra. In addition, one of Pfizer’s subsidiaries must plead guilty to felony misbranding charges.
» MORE

Study Raises Questions About Cost Savings From Preventive Care
Preventive services for the chronically ill may reduce health-care costs, but they are probably smaller than some advocates suggest
» MORE

Drug, Biotech Research Spending Hangs Tough
Overall U.S. corporate R&D spending is down 4% since the end of 2007, but some companies have chosen to buck the trend
» MORE

PharmRep Direct Features

Betting on Biotech’s Future
With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble
» MORE

Will Healthcare Reform Pay Off?
For the time being pharma is on board with President Obama’s healthcare reform program, but many are anxious about the final outlines of the reform package
» MORE

Arizona Pharmacists Administer Vaccines

Arizona has just joined the list of states where pharmacists are now qualified to administer immunizations
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?
Click Here to Vote

PharmRep Direct Quick Links
Little Change in New Merck Management

Pharma Booms In Eastern Europe

Confidential Marketing Plan Released



Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!